Literature DB >> 28179636

Association of urinary nerve growth factor levels with erectile function in young men with type 2 diabetes mellitus.

C-C Wang1,2, C-H Liao3, H-T Liu4, J-M Lin5, H-C Kuo4.   

Abstract

We investigated urine nerve growth factor (NGF) levels and erectile dysfunction in diabetic men <45 years of age. Urinary NGF levels were measured in 72 diabetic men and 20 control subjects without lower urinary tract symptoms or erectile dysfunction. Participants were evaluated using the International Prostate Symptom Score, quality of life index, Overactive Bladder Symptom Score (OABSS), the five-item version of the International Index of Erectile Function questionnaire (IIEF-5), the patient perception of bladder condition questionnaire, measurement of flow rate and post-void residual urine volume. The results showed that the diabetic men had significantly higher urinary normalized NGF/creatinine (Cr) levels compared to the healthy controls (0.48±1.2 vs 0.01±0.01, P=0.04). The increased urinary NGF/Cr levels correlated negatively with the IIEF-5 total score (P=0.03, coefficient=-0.26, -0.02 to -0.47). The 42 patients with urinary NGF/Cr levels <0.05 had higher IIEF-5 scores than the 30 patients with urinary NGF/Cr level ⩾0.05 (20.2±4.6 vs 16.9±6.7, P=0.03). We conclude that urinary NGF levels were associated with erectile dysfunction in the men with type 2 <45 years of age.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28179636     DOI: 10.1038/ijir.2017.2

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  16 in total

Review 1.  Urologic complications of diabetes.

Authors:  Jeanette S Brown; Hunter Wessells; Michael B Chancellor; Stuart S Howards; Walter E Stamm; Ann E Stapleton; William D Steers; Stephen K Van Den Eeden; Kevin T McVary
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

2.  Correlation between Lower Urinary Tract Symptoms (LUTS) and sexual function in benign prostatic hyperplasia: impact of treatment of LUTS on sexual function.

Authors:  Jae Hun Jung; Sung Uk Jae; Sung Chul Kam; Jae Seog Hyun
Journal:  J Sex Med       Date:  2009-06-02       Impact factor: 3.802

3.  Validation of stopwatch measurements of erection duration against responses to the sexual encounter profile and international index of erectile Function in patients treated with a phosphodiesterase type 5 inhibitor.

Authors:  James W Shaw; Gregory Reardon; David W Sandor; Raymond C Rosen; David M Ferguson
Journal:  J Sex Med       Date:  2010-01-26       Impact factor: 3.802

Review 4.  Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.

Authors:  Jay S Skyler; Richard Bergenstal; Robert O Bonow; John Buse; Prakash Deedwania; Edwin A M Gale; Barbara V Howard; M Sue Kirkman; Mikhail Kosiborod; Peter Reaven; Robert S Sherwin
Journal:  J Am Coll Cardiol       Date:  2009-01-20       Impact factor: 24.094

5.  The effect of vascular endothelial growth factor and brain-derived neurotrophic factor on cavernosal nerve regeneration in a nerve-crush rat model.

Authors:  P-S Hsieh; D J Bochinski; G T Lin; L Nunes; C S Lin; T F Lue
Journal:  BJU Int       Date:  2003-09       Impact factor: 5.588

Review 6.  Erectile dysfunction in diabetes mellitus.

Authors:  Lasantha S Malavige; Jonathan C Levy
Journal:  J Sex Med       Date:  2009-02-10       Impact factor: 3.802

Review 7.  Diabetic bladder dysfunction: current translational knowledge.

Authors:  Firouz Daneshgari; Guiming Liu; Lori Birder; Ann T Hanna-Mitchell; Samuel Chacko
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

8.  Previously unrecognized diabetes mellitus in sexually impotent men.

Authors:  S Deutsch; L Sherman
Journal:  JAMA       Date:  1980-11-28       Impact factor: 56.272

9.  Type 2 diabetes but not metabolic syndrome is associated with an increased risk of lower urinary tract symptoms and erectile dysfunction in men aged <45 years.

Authors:  Chung Cheng Wang; Michael B Chancellor; Jyh Ming Lin; Jui Hsiang Hsieh; Hong Jeng Yu
Journal:  BJU Int       Date:  2009-10-05       Impact factor: 5.588

10.  Markers of erectile dysfunction.

Authors:  Kelvin P Davies; Arnold Melman
Journal:  Indian J Urol       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.